This trial is designed to determine whether rapamycin is safe and effective treatment for patients with polycystic kidney disease (ADPKD). Patients will be followed by volumetric magnetic resonance imaging (MRI) to observe for change in kidney (and cyst) size. Blood and urine samples will also be collected to evaluate for change in biomarkers with treatment. ODM derived from: https://clinicaltrials.gov/show/NCT00920309
April 4, 2019
Please use this form for feedback, questions and suggestions for improvements.